SELLAS Life Sciences Group (RXK3.F) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.1
-0.08
-0.07
-0.05

Details

Expected EPS
-0.0661329542
Actual EPS
-0.051756
Surprise EPS
0.01
Surprise Percent
+21.74%

Description

SELLAS Life Sciences Group (RXK3.F) has reported earnings of -0.051756 per share for Q4 2025.

0 Comments

Share your thoughts